Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic Determinants of Clinical Outcomes in Rhabdomyosarcoma.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Mar 2020

Casey Dana L, Wexler Leonard H, Pitter Kenneth L, Samstein Robert M, Slotkin Emily K, Wolden Suzanne L

Abstract excerpt

PURPOSE: Increased availability of next-generation sequencing has allowed for the genomic characterization of a variety of pediatric tumors, although genomic determinants of response to treatment remain largely unknown. We sought to evaluate the genomic landscape and genomic determinants of clinical outcomes in rhabdomyosarcoma (RMS). EXPERIMENTAL DESIGN: Of 29,067 patients who underwent genomic profiling at our...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to High-Throughput Nucleotide Sequencing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Oncogene Proteins, Fusion

Share to Prognosis

Share to Rhabdomyosarcoma

Share to Survival Rate

Share to Tumor Suppressor Protein p53

Source

Open in PubMed Open full text

Identifiers

PMID: 31699828
DOI: 10.1158/1078-0432.CCR-19-2631
PMCID: PMC8693250

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic Determinants of Clinical Outcomes in Rhabdomyosarcoma.PMID 31699828Read ↗

Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.Semantic proximity Read ↗

Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.Semantic proximity Read ↗

Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group.Semantic proximity Read ↗

Pediatric RhabdomyosarcomaSemantic proximity Read ↗

Rhabdomyosarcoma: How Advanced Molecular Methods Are Shaping the Diagnostic and Therapeutic Paradigm.Semantic proximity Read ↗

Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-StudiengruppeSemantic proximity Read ↗

Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma.Semantic proximity Read ↗

Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular Biomarkers.Semantic proximity Read ↗

Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular BiomarkersSemantic proximity Read ↗

Germline Genetic Testing and Survival Outcomes Among Children With RhabdomyosarcomaSemantic proximity Read ↗

Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcomaSemantic proximity Read ↗

Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.